Old Mission Capital’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Old Mission Capital’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,337	Closed	-$5K	–	433
2016 Q2	$5K	Buy	+1,337	New	+$6.14K	﹤0.01%	309
2015 Q2	–	Sell	-7,524	Closed	-$136K	–	304
2015 Q1	$136K	Buy	+7,524	New	+$169K	0.03%	199

Other funds holding CTIC

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Old Mission Capital's CTIC Position: Q3 2016 in Review

Old Mission Capital sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2016, closing a stake of 1,337 shares — an estimated $5K sold.

Old Mission Capital first reported a position in CTIC in Q1 2015 and held it in 2 quarters. The position peaked at $136K in Q1 2015. 61 funds tracked by Wall St. Rank hold CTIC as of Q3 2016.

Old Mission Capital reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2016 after selling out during the quarter.
Old Mission Capital sold 1,337 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2016, an estimated $5K.
Old Mission Capital first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2015 and held it in 2 quarters.
Old Mission Capital's CTI BioPharma Corp. (DE) Common Stock position peaked at $136K in Q1 2015.
61 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2016.

Based on Old Mission Capital's 13F filing for Q3 2016, filed 14 Nov 2016.